RTX vs RXST · P/E 36, rev $88.60B vs rev $139.9M
RTX Corporation (RTX) versus Rxsight Inc (RXST) — a side-by-side from cached financials, not a winner call.
RTX Corporation (RTX) is a aerospace & defense company listed on NYSE. It is led by Chris Calio.
Rxsight Inc (RXST) is a medical devices company listed on NASDAQ.
Latest reported RTX revenue for 2025-12-31 was $88.60B. Net income was $6.73B. Revenue was up 9.7% from 2024-12-31 to 2025-12-31. RTX currently screens at market cap $259.34B and trailing P/E 36.2.
Latest reported RXST revenue for 2024-12-31 was $139.9M. Net income was -$27.5M. Revenue was up 57.1% from 2023-12-31 to 2024-12-31. RXST currently screens at market cap $198.3M.
RTX currently screens at market cap $259.34B and trailing P/E 36.2. RXST currently screens at market cap $198.3M.
Not investment advice. Open the RTX and RXST stock pages for the full models.
Not investment advice.